Approaches to Modelling the Human Immune Response in Transition of Candidates from Research to Development

Abstract

This review considers the steps required to evaluate a candidate biodefense vaccine or therapy as it emerges from the research phase, in order to transition it to development. The options for preclinical modelling of efficacy are considered in the context of the FDA’s Animal Rule

Similar works

Full text

thumbnail-image

Directory of Open Access Journals

redirect
Last time updated on 14/10/2017

This paper was published in Directory of Open Access Journals.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.